Dyslipidemia of Obesity Intervention in Teens
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 354
Summary
- Conditions
- Dyslipidemia
- Obesity
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 10 years and 19 years
- Gender
- Both males and females
Description
Randomized, double-blind, placebo-controlled clinical trial of pitavastatin for 2 years comparing the effect of study drug versus placebo on vascular measures in at least 354 adolescents with excess adiposity and CDO (defined as high non-HDL-C + high TG/HDL-C ratio or low HDL-C). Enrollment will tak...
Randomized, double-blind, placebo-controlled clinical trial of pitavastatin for 2 years comparing the effect of study drug versus placebo on vascular measures in at least 354 adolescents with excess adiposity and CDO (defined as high non-HDL-C + high TG/HDL-C ratio or low HDL-C). Enrollment will take place over 36 months.
Tracking Information
- NCT #
- NCT02956590
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Investigators
- Not Provided
Get Well Soon